Comment by
inthno on Nov 21, 2021 5:38pm
Wow , amazing such good news about all these other companies and that is why we are trading at a whopping 2.19 canadian. As canada fan says, just gotta wait a couple days for the news to filter out and then we are off to the races.
Comment by
inthno on Nov 21, 2021 5:41pm
also I have been told many times in the past to not rely on clinical trials.gov for updates as they are usually 2-3 months behind or more on the proper updates, this info from when onc used to talk to shareholders.
Comment by
Noteable on Nov 30, 2021 7:23pm
Gilead is presenting at SABC 2021 on December 07-10, 2021 on Trodelvy in TNBC while ONCY presents on its Phase 2 IRENE study also in TNBC. https://www.biospace.com/article/releases/gilead-s-bold-ambition-of-transforming-triple-negative-breast-cancer-treatment-to-be-highlighted-with-new-data-at-sabcs/
Comment by
unNoteable on Nov 30, 2021 7:56pm
and whilst Gilead will be presenting Phase III data. ONCY will be presenting safety run in data from maybe 1 patient, if we're lucky... the conclusion will be that it's safe and well tolerated... It'll take more then rat's backside data like this to move the pps...
Comment by
Noteable on Nov 30, 2021 8:48pm
Well well "R" ... you don't have much to say. Will your incessant uninformed bashing really end?
Comment by
Noteable on Dec 01, 2021 12:13pm
YES - Brilliant - since ONCY has setup the dynamics for its Big Pharma acquirer to run a faster and cheaper Phase 3 registration study thus making ONCY more attractive to multiple bidders rather than just one or three who are presently involved and working with ONCY.